AMVAC, Harvard announce mosquito control research collaboration agreement
AMVAC Chemical Corporation, a wholly owned subsidiary of American Vanguard Corporation, has entered into a Research Collaboration Agreement with Harvard University to develop and potentially commercialize new, Harvard-owned technology aimed at control of the Aedes aegypti mosquito, a viral disease vector. Aedes is the mosquito responsible for the spread of Zika, Dengue, Chikungungunya, and Yellow Fever viruses in many countries around the world. Under the collaboration agreement, AMVAC will support a research project led by Dr. Flaminia Catteruccia, Associate Professor of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health. The technology under study is the subject of a patent application filed by Harvard; the collaboration agreement grants AMVAC certain license options for commercial development of spray- or fog-based mosquito control products.